IL-17RB Antibody (MM0374-5P14) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-11673F
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Block/Neutralize, Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Mouse IgG2 Clone # MM0374-5P14
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Human recombinant IL-17RB (extracellular domain)
Reactivity Notes
0
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2
Applications for IL-17RB Antibody (MM0374-5P14) [FITC]
Application
Recommended Usage
Block/Neutralize
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: IL-17RB
Long Name
Interleukin 17B Receptor
Alternate Names
Evi27, IL-17 RB, IL-17 RH1, IL-17ER, IL17RB
Gene Symbol
IL17RB
Additional IL-17RB Products
Product Documents for IL-17RB Antibody (MM0374-5P14) [FITC]
Product Specific Notices for IL-17RB Antibody (MM0374-5P14) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...